Group items tagged

The National Institutes of Health (NIH) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in categorical program areas. The R21 activity code is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

The intent of this grant is to fund innovative psychological science research projects. Students in all fields of psychology and neuroscience and are APAGS members are eligible to submit. Funds for this $1,000 scholarship must be used to support the proposed research. This grant may be used for thesis, dissertation or other research.

Mark your calendar for the 2015 NIH Regional Seminar on Program Funding and Grants Administration in Baltimore, Maryland - May 6-8, 2015. This two-day seminar, with an optional third day of pre-seminar workshops, is ideal for anyone in the extramural research community who is new to working with NIH grants, including administrators, new and early stage investigators, and grant writers. Registration will open in early 2015.

The William T. Grant Scholars Program is for early-career researchers in the social, behavioral, and health sciences. We encourage Scholars to tackle important questions that will advance theory, policy, and practice for youth. Applicants identify new methods, disciplines, or content they want to learn, and propose five-year research plans that foster their growth in those areas.

This Funding Opportunity Announcement (FOA) invites research projects focused on the dynamic and mechanistic links between the maturation of brain circuits and behaviors across development in rodents and non-human primates. The goal is to build a foundation for understanding how interactions within and among brain regions change during pre- and post-natal development, allowing for the emergence of cognitive, affective and social behaviors. To this end, projects supported will focus on neurodevelopmental trajectories and investigate questions using in vivo neural measures in awake, behaving animals. This FOA seeks shorter, higher-risk R21 grant applicationsþff, whereas its companion funding opportunity seeksþff R01 grant applications.

This FOA invites Research and Development Center (P30) grant applications in demography, economics and health services research relevant to Alzheimer's Disease and Alzheimer's Related Dementias (AD/ADRD). Areas of focus that are especially encouraged are: a) national and international population trends in cognitive aging and AD/ADRD; b) demography of dementia care and caregiving; c) economic burden of AD/ADRD; d) impact of health care systems and long-term supports and services on outcomes for persons with dementia and their care providers; e) impact of health care financing policies on outcomes for persons with dementia and their care providers; f) how regulatory and economic incentives affect access, quality and health outcomes in health and long-term care systems for persons with dementia; g) disparities in quality and access to dementia care; h) effects of population-level health delivery and care interventions on outcomes of persons with dementia; and i) national and international projections of dementia caseload, incidence and prevalence. Center grant applications must include two mandatory Cores and may choose among three optional Cores. Centers are required to work collaboratively with the Coordinating Center to be funded via RFA-AG-20-003.  

This FOA invites Research and Development Center (P30) grant applications in the areas of demography and economics of aging, including relevant interdisciplinary areas rooted in population-based social science research. Areas of focus that are especially encouraged are: a) socioeconomic status (SES) disparities at older ages, including geographic disparities; b) the reasons for poor U.S. performance in health and mortality in international comparisons; c) trends and dynamics in old-age disability; d) cohort trends in obesity and its sequelae; e) family demography including the demography of care and caregiving for chronic disease, disability and Alzheimer's Disease and Alzheimer's-Related Dementias (AD/ADRD); and f) long-term supports and services for the disabled elderly population. Applications that wish to focus exclusively on AD/ADRD should submit to RFA-AG-20-002. Center grant applications must include two mandatory Cores and may choose among three optional Cores. Centers are required to work collaboratively with the Coordinating Center to be funded via RFA-AG-20-003.  

With more than fifty thousand members and certified professionals from ninety countries around the globe, the American College of Sports Medicine represents seventy occupations within the field of sports medicine. From academicians to students and from personal trainers to physicians, ACSM is dedicated to helping people worldwide live longer, healthier lives. To advance this mission, the association established the Research Grant Program through the ACSM Foundation, its charitable arm, in 1989. Through the program, grants of up to $10,000 will be awarded to support basic and applied research in exercise science. Funding is primarily targeted to new or junior investigators within seven years of attaining a terminal degree (e.g., PhD, EdD) and is expected to provide seed money support after which further funding would be sought from other sources. Grants are open to all ACSM members in good standing. See the American College of Sports Medicine website for complete program guidelines and application instructions.

This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, proposing the development of innovative, collaborative research projects on brain and other nervous system function and disorders throughout life, relevant to low- and middle-income countries (LMICs). Research on neurological, mental, behavioral, alcohol and substance use disorders may span the full range of science from basic to implementation research. Scientists in the United States (U.S.) or upper-middle income countries (UMICs) are eligible to partner with scientists in LMIC institutions. Scientists in upper middle-income LMICs (UMICs) are also eligible to partner directly with scientists at other LMIC institutions with or without out a US partner. Income categories used are as defined by the World Bank at http://data.worldbank.org/about/country-classifications/country-and-lending-groups. These grants are expected to foster the development of more comprehensive research programs that contribute to the long-term goals of building sustainable research capacity in LMICs to address nervous system development, function and impairment throughout life and to lead to diagnostics, prevention, treatment and implementation strategies. The proposed work may also contribute to developing a base for research networking and evidence-based policy beyond the specific research project.

Grants of up to $50,000 will be awarded in support of relevant migraine research, with priority given to translational projects and projects related to migraine variants, childhood migraine, and chronic migraine. Grant funds must be used exclusively for research and directly related research equipment. Capital expenditures, administrative costs, and institutional overhead (including IRB approval, publication costs, and travel costs) will not be funded.

The BrightFocus Foundation provides research funds for U.S. and international researchers pursuing high-risk studies that illuminate areas for which there currently is little understanding, helping to bring to light crucial knowledge about Alzheimer's disease, glaucoma, and macular degeneration. The organization's mission is to save mind and sight by funding innovative research worldwide and by promoting better health through education. To that end, the foundation is accepting applications for its Alzheimer's Disease Research and National Glaucoma Research programs. 1) Alzheimer's Disease Research: Grants of up to $300,000 over three years will be awarded to researchers for innovative investigator-initiated research projects. The program is designed to give scientists the opportunity to develop the preliminary data necessary to be considered competitive for larger government or corporate types of sponsorship. Applications must be received no later than October 18, 2017. 2) National Glaucoma Program: Grants of up to $150,000 over two years will be awarded to researchers for innovative investigator-initiated glaucoma-related research projects. The program is designed to give scientists the opportunity to develop the preliminary data necessary to be considered competitive for larger government or corporate types of sponsorship. Typically these awards are made to junior investigators, or to more established investigators who are proposing particularly innovative research.

The National Multiple Sclerosis Society mobilizes people and resources to find a cure for and address challenges faced by those affected by MS. To that end, the society is accepting applications for its Pilot Grant Program. The program funds high-risk pilot grants in support of novel ideas that may serve to advance its mission of stopping MS progression, restoring function, and improving quality of life for those with MS. The program supports fundamental as well as applied studies, both non-clinical or clinical in nature, including projects in patient management, care, and rehabilitation. One-year grants of up to $44,000 will be awarded to test innovative, cutting-edge ideas or untested methods, and to gather sufficient preliminary data that can be used to apply for longer-term funding. Researchers who have completed their postdoctoral training are invited to apply. Individuals who are currently postdoctoral fellows or the equivalent, or who are graduate/medical students are not eligible for support under this program. Pre-applications must be received no later than January 8, 2018.

This Funding Opportunity Announcement (FOA) invites research grant applications to decipher pathways and mechanisms responsible for HIV-1 induced central nervous system (CNS) dysfunction seen in virally suppressed HIV-1 positive patients, by understanding the causal role played by altered neuronal circuits, neuronal receptors and neuronal networks. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. This RFA [RFA-MH-18-610] uses the R01 grant mechanism while the companion RFA [RFA-MH-18-611] uses the R21 mechanism. High risk/high payoff projects that lack preliminary data may be most appropriate for the R21 [RFA-MH-18-611] mechanism, while applicants with preliminary data and a discrete, specified, circumscribed project can apply using the R01 [RFA-MH-18-610] mechanism.

As part of this mission, the foundation is seeking applications for scientific research projects with the potential to significantly advance the field toward an effective understanding of the mechanisms of cerebrovascular disease. TAAF grants respond to the cerebrovascular community's need for projects that highlight innovative research strategies that will support the development of novel cerebrovascular therapies, clinical management, and recovery for patients. To that end, grants of up to $25,000 will be awarded to investigators at any level of experience. However, grant recipients will be expected to present their research at the Aneurysm and AVM Foundation's annual meeting or Awareness Walk event.

This funding opportunity announcement (FOA) encourages Research Project Grant (R01) applications from institutions/ organizations addressing preclinical research in model organisms of neurodevelopmental disorders. Applications submitted to this FOA should propose to develop, validate, and/or calibrate outcome measures, surrogate markers, and biomarkers in model organisms that can inform and effectively translate to human clinical trials for individuals with intellectual and developmental disabilities (IDD).

NOTICE:  Applications are submitted to the American Heart Association via Grants@Heart, a Web-based application system.  Grants@Heart is scheduled to open on May 15, 2013.  In the meantime, please review the program listings, instructions and information in preparation for your application. 

This Funding Opportunity Announcement (FOA) is issued by the National Institute of Neurological Disorders and Stroke (NINDS) in conjunction with the NIH Pain Consortium. It solicits R21 grant applications from institutions/organizations to perform innovative research that will elucidate the mechanisms underlying migraine, expand our current knowledge of the role of genetic, physiological, biopsychosocial, and environmental influences in migraine susceptibility and progression, and explore new therapeutic targets and therapies for acute migraine management and longer term prevention.

This Funding Opportunity Announcement (FOA) is issued by the National Institute of Neurological Disorders and Stroke (NINDS) in conjunction with the NIH Pain Consortium. It solicits R01 grant applications from institutions/organizations to perform innovative research that will elucidate the mechanisms underlying migraine, expand our current knowledge of the role of genetic, physiological, biopsychosocial, and environmental influences in migraine susceptibility and progression, and explore new therapeutic targets and therapies for acute migraine management and longer term prevention.

This funding opportunity announcement (FOA) solicits R01 grant applications from applicant organizations that propose to develop and implement interventions to remediate age-related cognitive decline. A crucial feature of these applications will be the embedding of the testing of the proposed intervention into a measurement framework that will: 1) help elucidate its mechanism of action; 2) identify specific individuals who are more likely or less likely to benefit from the intervention, and 3) examine whether adaptive plastic changes have occurred in the structure or function of the CNS as a result of the intervention, and whether these neural changes help explain the pattern of improvement seen in cognitive functioning. Although projects may include an observational component, the interventions developed should be tested in a randomized clinical trial (RCT).

JTSSF welcomes submissions of grant requests for funding covering all aspects of stroke prevention, treatment and awareness.